{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:55:37Z","timestamp":1792659337513,"version":"4.5.0"},"reference-count":54,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibroblast growth factor 23 (FGF23) is a recently characterized protein likely involved in the regulation of serum phosphate homeostasis. Increased circulating levels of FGF23 have been reported in patients with renal phosphate-wasting disorders, but it is unclear whether FGF23 is the direct mediator responsible for the decreased phosphate transport at the proximal renal tubules and the altered vitamin D metabolism associated with these states. To examine this question, we generated transgenic mice expressing and secreting from the liver human FGF23 (R176Q), a mutant form that fails to be degraded by furin proteases. At 1 and 2 months of age, mice carrying the transgene recapitulated the biochemical (decreased urinary phosphate reabsorption, hypophosphatemia, low serum 1,25-dihydroxyvitamin D3) and skeletal (rickets and osteomalacia) alterations associated with these disorders. Unexpectantly, marked changes in parameters of calcium homeostasis were also observed, consistent with secondary hyperparathyroidism. Moreover, in the kidney the anticipated alterations in the expression of hydroxylases associated with vitamin D metabolism were not observed despite the profound hypophosphatemia and increased circulating levels of PTH, both major physiological stimuli for 1,25-dihydroxyvitamin D3 production. Our findings strongly support the novel concept that high circulating levels of FGF23 are associated with profound disturbances in the regulation of phosphate and vitamin D metabolism as well as calcium homeostasis and that elevated PTH levels likely also contribute to the renal phosphate wasting associated with these disorders.<\/jats:p>","DOI":"10.1210\/en.2004-0233","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T00:13:33Z","timestamp":1091146413000},"page":"5269-5279","source":"Crossref","is-referenced-by-count":278,"title":["Transgenic Mice Overexpressing Human Fibroblast Growth Factor 23 (R176Q) Delineate a Putative Role for Parathyroid Hormone in Renal Phosphate Wasting Disorders"],"prefix":"10.1210","volume":"145","author":[{"given":"Xiuying","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengshun","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goltzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Karaplis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071612585118800_R1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0031-3955(05)70485-5","article-title":"New perspectives on the biology and treatment of X-linked hypophosphatemic rickets.","volume":"44","author":"Carpenter","year":"1997","journal-title":"Pediatr Clin North Am"},{"key":"2020071612585118800_R2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","article-title":"Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.","volume":"82","author":"Econs","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612585118800_R3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S8756-3282(00)00334-3","article-title":"Tumor-induced osteomalacia and the regulation of phosphate homeostasis.","volume":"27","author":"Kumar","year":"2000","journal-title":"Bone"},{"key":"2020071612585118800_R4","first-page":"411","article-title":"Hypophosphataemic osteomalacia in fibrous dysplasia.","volume":"45","author":"Dent","year":"1976","journal-title":"Q J Med"},{"key":"2020071612585118800_R5","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612585118800_R6","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1073\/pnas.111154898","article-title":"FGF23, hypophosphatemia, and rickets: has phosphatonin been found?","volume":"98","author":"Strewler","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612585118800_R7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/ndt\/17.6.958","article-title":"Is FGF23 the long sought after phosphaturic factor phosphatonin?","volume":"17","author":"Silve","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2020071612585118800_R8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00424-002-0839-4","article-title":"Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders.","volume":"444","author":"Tenenhouse","year":"2002","journal-title":"Pflugers Arch"},{"key":"2020071612585118800_R9","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612585118800_R10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.","volume":"112","author":"Berndt","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612585118800_R11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"2020071612585118800_R12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets.","volume":"11","year":"1995","journal-title":"Nat Genet"},{"key":"2020071612585118800_R13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.","volume":"26","year":"2000","journal-title":"Nat Genet"},{"key":"2020071612585118800_R14","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"key":"2020071612585118800_R15","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia.","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med"},{"key":"2020071612585118800_R16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612585118800_R17","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency.","volume":"278","author":"Bai","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071612585118800_R18","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia: a complex dance of factors.","volume":"348","author":"Carpenter","year":"2003","journal-title":"N Engl J Med"},{"key":"2020071612585118800_R19","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia.","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612585118800_R20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis.","volume":"18","author":"Weber","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2020071612585118800_R21","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"2020071612585118800_R22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","article-title":"FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.","volume":"284","author":"Bowe","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612585118800_R23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj20030287","article-title":"Human recombinant endopeptidase PHEX has a strict S1\u2032 specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.","volume":"373","author":"Campos","year":"2003","journal-title":"Biochem J"},{"key":"2020071612585118800_R24","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071612585118800_R25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration.","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"key":"2020071612585118800_R26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2474-3-16","article-title":"Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)2D3 response to short-term treatment with 1,25-dihydroxyvitamin D3 in vivo.","volume":"3","author":"Miao","year":"2002","journal-title":"BMC Musculoskelet Disord"},{"key":"2020071612585118800_R27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/33.8.2410480","article-title":"A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.","volume":"33","author":"Lopez-De Leon","year":"1985","journal-title":"J Histochem Cytochem"},{"key":"2020071612585118800_R28","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1210\/endo.142.5.8146","article-title":"Tissue-specific targeting of the Pthrp gene: the generation of mice with floxed alleles.","volume":"142","author":"He","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612585118800_R29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/002215540205000305","article-title":"Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage.","volume":"50","author":"Miao","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"2020071612585118800_R30","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/endo.142.2.7976","article-title":"Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition.","volume":"142","author":"Miao","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612585118800_R31","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/me.2002-0113","article-title":"Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression.","volume":"16","author":"Bai","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2020071612585118800_R32","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1016\/S0021-9258(18)53085-4","article-title":"A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice.","volume":"268","author":"Simonet","year":"1993","journal-title":"J Biol Chem"},{"key":"2020071612585118800_R33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"2020071612585118800_R34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612585118800_R35","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing Fibroblast growth factor 23 under the control of the \u03b11(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612585118800_R36","first-page":"879","article-title":"A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.","volume":"75","author":"Sullivan","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612585118800_R37","first-page":"1378","article-title":"Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.","volume":"78","author":"Carpenter","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612585118800_R38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2265.1995.tb01863.x","article-title":"Autonomous hyperparathyroidism in X-linked hypophosphataemia.","volume":"42","author":"Knudtzon","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612585118800_R39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004670050669","article-title":"PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia.","volume":"13","author":"Blydt-Hansen","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"2020071612585118800_R40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1210\/endo-111-2-650","article-title":"Secondary hyperparathyroidism in X-linked hypophosphatemic mice.","volume":"111","author":"Kiebzak","year":"1982","journal-title":"Endocrinology"},{"key":"2020071612585118800_R41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/8756-3282(95)00420-3","article-title":"Effects of altered diet on serum levels of 1,25-dihydroxyvitamin D and parathyroid hormone in X-linked hypophosphatemic (Hyp and Gy) mice.","volume":"18","author":"Meyer Jr","year":"1996","journal-title":"Bone"},{"key":"2020071612585118800_R42","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF02555750","article-title":"Studies in a patient with tumor-induced hypophosphatemic osteomalacia.","volume":"38","author":"Ryan","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"2020071612585118800_R43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3904\/kjim.1997.12.1.89","article-title":"Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.","volume":"12","author":"Yang","year":"1997","journal-title":"Korean J Intern Med"},{"key":"2020071612585118800_R44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-004-1443-y","article-title":"The enigma of hyperparathyroidism in hypophosphatemic rickets.","volume":"19","author":"Schmitt","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"2020071612585118800_R45","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.273.22.13729","article-title":"Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity.","volume":"273","author":"Lipman","year":"1998","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"2020071612585118800_R46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj3550707","article-title":"Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107\u2013139 as a substrate and osteocalcin, PPi and phosphate as inhibitors","volume":"355","author":"Boileau","year":"2001","journal-title":"Biochem J"},{"key":"2020071612585118800_R47","doi-asserted-by":"crossref","first-page":"E837","DOI":"10.1152\/ajpendo.2001.281.4.E837","article-title":"Analysis of recombinant Phex: an endopeptidase in search of a substrate","volume":"281","author":"Guo","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612585118800_R48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2020071612585118800_R49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/abbi.2000.1964","article-title":"Regulation of the porcine 1,25-dihydroxyvitamin D3\u201324-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 and parathyroid hormone in AOK-B50 cells.","volume":"381","author":"Zierold","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"2020071612585118800_R50","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1073\/pnas.241516798","article-title":"Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.","volume":"98","author":"Zierold","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612585118800_R51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1359\/jbmr.2003.18.3.434","article-title":"Abnormal regulation of renal 25-hydroxyvitamin D-1\u03b1-hydroxylase activity in X-linked hypophosphatemia: a translational or posttranslational defect.","volume":"18","author":"Fujiwara","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2020071612585118800_R52","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","article-title":"Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.","volume":"95","author":"Beck","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612585118800_R53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","article-title":"Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter.","volume":"347","author":"Prie","year":"2002","journal-title":"N Engl J Med"},{"key":"2020071612585118800_R54","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/en.2003-1097","article-title":"Skeletal abnormalities in Pth-null mice are influenced by dietary calcium.","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/145\/11\/5269\/9026155\/endo5269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/145\/11\/5269\/9026155\/endo5269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T17:29:27Z","timestamp":1624555767000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/145\/11\/5269\/2500780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2004-0233","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,1]]}}}